Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial-Reference-Cited by-同舟云学术

Safety and Efficacy of Daptomycin as First-Line Treatment for Complicated Skin and Soft Tissue Infections in Elderly Patients: An Open-Label, Multicentre, Randomized Phase IIIb Trial

Published:2013-08-29 Issue:10 Volume:30 Page:829-836
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Konychev Alexander,Heep Markus,Moritz Rose K. C.,Kreuter Alexander,Shulutko Alexander,Fierlbeck Gerhard,Bouylout Kamel,Pathan Rashidkhan,Trostmann Uwe,Chaves Ricardo L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-013-0114-8.pdf

Reference14 articles.

1. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis. 2003;37(11):1453–60.

2. McClelland RS, Fowler VG Jr, Sanders LL, et al. Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med. 1999;159(11):1244–7.

3. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Diabetes Care. 2004;27(5):1047–53.

4. Pather M. The prevalence of renal impairment in the elderly hospitalized population. Int J Gen Med. 2009;2(1):117–9.

5. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8(1):117.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data Study on Risk Factors Associated with Acute Kidney Damage in Patients Treated with Anti-MRSA Antibiotics;Future Pharmacology;2024-01-09

2. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents;Expert Review of Anti-infective Therapy;2023-11-02

3. Antimicrobial Peptides in Infectious Diseases and Beyond—A Narrative Review;Life;2023-07-28

4. Insufficient Representation of Patients With Obesity in Randomized Controlled Trials Evaluating the Efficacy and Safety of Antimicrobials for Treatment of Skin and Skin Structure Infections: A Scoping Review;Open Forum Infectious Diseases;2023-03-01

5. Data mining for adverse drug reaction signals of daptomycin based on real-world data: a disproportionality analysis of the US Food and Drug Administration adverse event reporting system;International Journal of Clinical Pharmacy;2022-09-30